Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Orciprenaline sulfate 20mg tablet (substance) |
Is a |
False |
Orciprenaline sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metaproterenol sulphate 10mg/5mL syrup |
Is a |
False |
Orciprenaline sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metaproterenol sulfate 0.4%/2.5mL inhalation solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metaproterenol sulfate 0.6%/2.5mL inhalation solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely orciprenaline sulfate 50 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metaproterenol sulfate 50mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metaproterenol sulfate 10mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metaproterenol sulfate 15mg/mL aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metaproterenol sulfate 0.65mg/inh aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Orciprenaline sulfate 2 mg/mL oral solution |
Has precise active ingredient |
True |
Orciprenaline sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Orciprenaline sulfate 2 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Orciprenaline sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely orciprenaline sulfate 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Orciprenaline sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely orciprenaline sulfate 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Orciprenaline sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely orciprenaline sulfate 50 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
Has basis of strength substance (attribute) |
True |
Orciprenaline sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely orciprenaline sulfate 50 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
Has precise active ingredient |
True |
Orciprenaline sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely orciprenaline sulfate 15 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
Has basis of strength substance (attribute) |
True |
Orciprenaline sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely orciprenaline sulfate 15 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
Has precise active ingredient |
True |
Orciprenaline sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |